Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung

Nature Medicine

Volumn 10, Issue 10, 2004, Pages 1095-1103

  Lee, Chun Geun ^a   Link, Holger ^a   Baluk, Peter ^b   Homer, Robert J ^a   Chapoval, Svetlana ^a   Bhandari, Vineet ^a   Kang, Min Jong ^a   Cohn, Lauren ^a   Kim, Yoon Keun ^a   McDonald, Donald M ^b   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REGENERON; SU 1498; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN INHIBITOR;

ANIMAL CELL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EDEMA; INFLAMMATION; LUNG PARENCHYMA; METAPLASIA; MOUSE; MUCUS; MUSCLE CELL; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN INDUCTION; REVASCULARIZATION; TH2 CELL; TRANSGENIC MOUSE; VASCULAR DISEASE; VASCULAR REMODELING;

AIRWAY OBSTRUCTION; ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-13; LUNG; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; BRONCHUS; MUS MUSCULUS;

EID: 7044260315     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1105     Document Type: Article

References (51)

1. Wills-Karp, M. & Chiaramonte, M. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9, 21-27 (2003).
2. Elias, J.A., Zhu, Z., Chupp, G. & Homer, R.J. Airway remodeling in asthma. J. Clin. Invest. 104, 1001-1006 (1999).
3. Elias, J.A. et al. New insights into the pathogenesis of asthma. J. Clin. Invest. 111, 291-297 (2003).
4. Vrugt, B. et al. Bronchial angiogenesis in severe glucocorticoid- dependent asthma. Eur. Respir. J. 15, 1014-1021 (2000).
5. Salvato, G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56, 902-906 (2001).
6. Li, X. & Wilson, J.W. Increased vascularity of the bronchial mucosa in mild asthma. Am. J. Respir. Crit. Care Med. 156, 229-233 (1997).
7. Lee, Y.C. & Lee, H.K. Vascular endothelial growth factor in patients with acute asthma. J. Allergy Clin. Immunol. 107, 1106-1108 (2001).
8. Orsida, B.E. et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am. J. Respir. Crit. Care Med. 164, 117-121 (2001).
9. Hogg, J.C. Vascularity in asthmatic airways: Relation to inhaled steroid dose. Thorax 54, 283 (1999).
10. Hoshino, M., Nakamura, Y. & Hamid, Q.A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J. Allergy Clin. Immunol. 107, 1034-1038 (2001).
11. Hoshino, M., Takahashi, M. & Aoike, N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J. Allergy Clin. Immunol. 107, 295-301 (2001).
12. Charan, N.B., Baile, E.M. & Pare, P.D. Bronchial vascular congestion and angiogenesis. Eur. Respir. J. 10, 1173-1180 (1997).
13. Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463 (2000).
14. Antony, A.B., Tepper, R.S. & Mohammed, K.A. Cockroach extract antigen increases bronchial airway epithelial permeability. J. Allergy Clin. Immunol. 110, 589-595 2002).
15. Senger, D.R. et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12, 303-324 (1993).
16. Gerber, H.P., Dixit, V. & Ferrara, N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273, 13313-13316 (1998).
17. Clauss, M. Molecular biology of the VEGF and the VEGF receptor family. Semin. Thromb. Hemost. 26, 561-569 (2000).
18. Kanazawa, H., Hirata, K. & Yoshikawa, J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 57, 885-888 (2002).
19. Asai, K. et al. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J. Allergy Clin. Immunol. 110, 571-575 (2002).
20. Kaner, R.J. et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 22, 657-664 (2000).
21. Partovian, C. et al. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am. J. Respir. Cell Mol. Biol. 23, 762-771 (2000).
22. Schwarze, J. & Gelfand, E.W. Respiratory viral infections as promoters of allergic sensitization and asthma in animal models. Eur. Respir. J. 19, 341-349 (2002).
23. Eisenbarth, S.C. et al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196, 1645-1651 (2002).
24. Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C. & DeKruyff, R.H. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3, 715-720 (2002).
25. Sigurs, N., Bjarnason, R., Sigurbergsson, F. & Kjellman, B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161, 1501-1507 (2000).
26. Lee, C.G. et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am. J. Respir. Cell Mol. Biol. 23, 662-669 (2000).
27. Zeng, X., Wert, S.E., Federici, R., Peters, K.G. & Whitsett, J.A. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev. Dyn. 211, 215-227 (1998).
28. Ray, P. et al. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J. Clin. Invest. 100, 2501-2511 (1997).
29. Ohta, Y. et al. Vascular endothelial growth factor expression in airways of patients with lung cancer: a possible diagnostic tool of responsive angiogenic status on the host side. Chest 121, 1624-1627 (2002).
30. Meyer, K.C., Cardoni, A. & Xiang, Z.Z. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J. Lab. Clin. Med. 135, 332-338 (2000).
31. Nishigaki, Y. et al. Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur. Respir. J. 21, 774-778 (2003).
32. Finotto, S. et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295, 336-338 (2002).
33. Hahn, R.G. Endotoxin boosts the vascular endothelial growth factor (VEGF) in rabbits. J. Endotoxin. Res. 9, 97-100 (2003).
34. Payne, D.N. et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167, 78-82 (2003).
35. Matsui, E.G. et al. Cockroach allergen exposure and sensitization in suburban middle-class children with asthma. J. Allergy Clin. Immunol. 112, 87-92 (2003).
36. Corne, J. et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J. Clin. Invest. 106, 783-791. (2000).
37. Lee, Y.C., Kwak, Y.-G. & Song, C.H. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 168, 3595-3600 (2002).
38. Vermaelen, K.Y. & Pauwels, R.A. Accelerated airway dendritic cell maturation, trafficking and elimination in a mouse model of asthma. Am. J. Respir. Cell Mol. Biol. (2003).
39. Gabrilovich, D.I., Ishida, T., Nadaf, S., Ohm, J.E. & Carbone, D.P. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin. Cancer. Res. 5, 2963-2970 (1999).
40. Matsuyama, W. et al. Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology 106, 96-101 (2002).
41. Leigh, R. et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am. J. Respir. Crit. Care Med. 169, 860-867 (2004).
42. Lee, C.G. et al. Transgenic overexpression of interleukin (ID-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem. 277, 35466-35474 (2002).
43. 1. J. Exp. Med. 194, 809-821 (2001).
44. Zhu, Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production. J. Clin. Invest. 103, 779-788 (1999).
45. Thurston, G., Baluk, P., Hirata, A. & McDonald, D.M. Permeability related changes revealed at endothelial cell borders in inflamed vessels by lectin staining. Am. J. Physiol. 271, H2547-H2562 (1996).
46. Baluk, P. et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am. J. Pathol. (in the press).
47. Tang, W. et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J. Clin. Invest. 98, 2845-2853 (1996).
48. Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L., Greenberg, D.A. Vascular endothelial growth factor stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 99, 11946-11950 (2002).
49. Wang, J. et al. IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J. Immunol. 165, 2222-2231 (2000).
50. Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040-1050 (2004).
51. Conn, L., Homer, R.J., Marinov, A., Rankin, J. & Bottomly, K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186, 1737-1747 (1997).